British Journal of Cancer - Table of Contents alert Volume 117 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 117, Issue 1 (1-155) Published online 27 June 2017 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Epidemiology Also new today Advance online publication Digital Edition Follow us on Twitter Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement We are pleased to announce that the Impact Factor* for the British Journal of Cancer is now 6.176 - an increase from 5.569 last year. The British Journal of Cancer is ranked 32 of 217 in the oncology category. The journal would like to thank all our authors, reviewers and readers for their continued support. *2016 Journal Citation Reports (Clarivate Analytics, 2017)  Submit your research >>>   Minireview Top Hallmarks of response to immune checkpoint blockade Alexandria P Cogdill, Miles C Andrews and Jennifer A Wargo Br J Cancer 2017 117: 1-7; advance online publication, May 18, 2017; 10.1038/bjc.2017.136 Abstract | Full Text Clinical Studies Top Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group F Koinis, S Agelaki, V Karavassilis, N Kentepozidis, E Samantas, S Peroukidis, P Katsaounis, E Hartabilas, I I Varthalitis, I Messaritakis, G Fountzilas, V Georgoulias and A Kotsakis Br J Cancer 2017 117: 8-14; advance online publication, May 16, 2017; 10.1038/bjc.2017.137 Abstract | Full Text Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer Teresa E Brown, Merrilyn D Banks, Brett G M Hughes, Charles Y Lin, Lizbeth M Kenny and Judith D Bauer Br J Cancer 2017 117: 15-24; advance online publication, May 23, 2017; 10.1038/bjc.2017.138 Abstract | Full Text Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach Yukinori Kurokawa, Han-Kwang Yang, Haruhiko Cho, Min-Hee Ryu, Toru Masuzawa, Sook Ryun Park, Sohei Matsumoto, Hyuk-Joon Lee, Hiroshi Honda, Oh Kyoung Kwon, Takashi Ishikawa, Kyung Hee Lee, Kazuhito Nabeshima, Seong-Ho Kong, Toshio Shimokawa, Jeong-Hwan Yook, Yuichiro Doki, Seock-Ah Im, Seiichi Hirota, Seokyung Hahn, Toshirou Nishida and Yoon-Koo Kang Br J Cancer 2017 117: 25-32; advance online publication, May 23, 2017; 10.1038/bjc.2017.144 Abstract | Full Text A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus) Glen J Weiss, Jordan Waypa, Lisa Blaydorn, Jessica Coats, Kayla McGahey, Ashish Sangal, Jiaxin Niu, Cynthia A Lynch, John H Farley and Vivek Khemka Br J Cancer 2017 117: 33-40; advance online publication, June 6, 2017; 10.1038/bjc.2017.145 Abstract | Full Text Translational Therapeutics Top High-energy particle beam and gamma radiation exposure, familial relatedness and cancer in mice Pavel Chernyavskiy, Elijah F Edmondson, Michael M Weil and Mark P Little Br J Cancer 2017 117: 41-50; advance online publication, May 23, 2017; 10.1038/bjc.2017.141 Abstract | Full Text Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice Miika Martikainen, Janne Ruotsalainen, Johanna Tuomela, Pirkko Härkönen, Magnus Essand, Jari Heikkilä and Ari Hinkkanen Br J Cancer 2017 117: 51-55; advance online publication, May 30, 2017; 10.1038/bjc.2017.151 Abstract | Full Text Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis Deeksha Pal, Suman Suman, Venkatesh Kolluru, Sophia Sears, Trinath P Das, Houda Alatassi, Murali K Ankem, Jonathan H Freedman and Chendil Damodaran Br J Cancer 2017 117: 56-64; advance online publication, June 6, 2017; 10.1038/bjc.2017.143 Abstract | Full Text Molecular Diagnostics Top Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC Carina Strell, Karin Jessica Norberg, Artur Mezheyeuski, Jonas Schnittert, Praneeth R Kuninty, Carlos Fernández Moro, Janna Paulsson, Nicolai Aagaard Schultz, Dan Calatayud, Johannes Matthias Löhr, Oliver Frings, Caroline Sophie Verbeke, Rainer Lothar Heuchel, Jai Prakash, Julia Sidenius Johansen and Arne Östman Br J Cancer 2017 117: 65-77; advance online publication, May 18, 2017; 10.1038/bjc.2017.140 Abstract | Full Text MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1 Liang-liang Chen, Zhou-jing Zhang, Zhan-bo Yi and Jian-jun Li Br J Cancer 2017 117: 78-88; advance online publication, June 1, 2017; 10.1038/bjc.2017.150 Abstract | Full Text MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells Yu-Xin Cui, Robyn Bradbury, Valentina Flamini, Bo Wu, Nicola Jordan and Wen G Jiang Br J Cancer 2017 117: 89-101; advance online publication, June 1, 2017; 10.1038/bjc.2017.156 Abstract | Full Text CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells D Maciaczyk, D Picard, L Zhao, K Koch, D Herrera-Rios, G Li, V Marquardt, D Pauck, T Hoerbelt, W Zhang, D M Ouwens, M Remke, T Jiang, H J Steiger, J Maciaczyk and U D Kahlert Br J Cancer 2017 117: 102-112; advance online publication, June 1, 2017; 10.1038/bjc.2017.157 Abstract | Full Text Genetics & Genomics Top Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells Jenni Nikkilä, Rahul Kumar, James Campbell, Inger Brandsma, Helen N Pemberton, Fredrik Wallberg, Kinga Nagy, Ildikó Scheer, Beata G Vertessy, Artur A Serebrenik, Valentina Monni, Reuben S Harris, Stephen J Pettitt, Alan Ashworth and Christopher J Lord Br J Cancer 2017 117: 113-123; advance online publication, May 23, 2017; 10.1038/bjc.2017.133 Abstract | Full Text A meta-analysis of CXCL12 expression for cancer prognosis Harsh Samarendra, Keaton Jones, Tatjana Petrinic, Michael A Silva, Srikanth Reddy, Zahir Soonawalla and Alex Gordon-Weeks Br J Cancer 2017 117: 124-135; advance online publication, May 23, 2017; 10.1038/bjc.2017.134 Abstract | Full Text Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia Sanjiban Chakrabarty, Vinay Koshy Varghese, Pranoy Sahu, Pradyumna Jayaram, Bhadravathi M Shivakumar, Cannanore Ganesh Pai and Kapaettu Satyamoorthy Br J Cancer 2017 117: 136-143; advance online publication, May 18, 2017; 10.1038/bjc.2017.148 Abstract | Full Text Epidemiology Top Frozen shoulder and risk of cancer: a population-based cohort study Alma B Pedersen, Erzsébet Horváth-Puhó, Vera Ehrenstein, Mikael Rørth and Henrik T Sørensen Br J Cancer 2017 117: 144-147; advance online publication, May 18, 2017; 10.1038/bjc.2017.146 Abstract | Full Text Subcutaneous adiposity is an independent predictor of mortality in cancer patients Maryam Ebadi, Lisa Martin, Sunita Ghosh, Catherine J Field, Richard Lehner, Vickie E Baracos and Vera C Mazurak Br J Cancer 2017 117: 148-155; advance online publication, June 6, 2017; 10.1038/bjc.2017.149 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.